Earnings Call · Q1 FY2021·2021-05-05

Q1 21EPS +27.50%·Rev n/aQ4 20EPS -13.79%·Rev n/aQ3 20EPS +3.57%·Rev n/aQ2 20EPS +7.14%·Rev n/a⚠ consensus missing

Adaptive Biotechnologies Corp ADPT

Karina Calzadilla — Investor Relations

Chad Robins — Chief Executive Officer

Julie Rubinstein — Chief Commercial Officer

Chad Cohen — Chief Financial Officer

+3.2%1d on move date3d−9.1%5d−7.2%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ADPT calls or request research access.

More ADPT calls Browse calls Request research access